Copyright
©2011 Baishideng Publishing Group Co.
World J Hepatol. Jun 27, 2011; 3(6): 147-156
Published online Jun 27, 2011. doi: 10.4254/wjh.v3.i6.147
Published online Jun 27, 2011. doi: 10.4254/wjh.v3.i6.147
Table 1 Percent of positive cases, for HBs antibodies (IgG) by ELISA in the three studied population
| Group IChildren (2- < 4 years)N=200 | Group IIChildren (4-13 years)N =400 | Group IIIAdults (20-47 years)N =100 | TotalNoN =700 | |
| Anti-HBs IgG | n (%) | n (%) | n (%) | n (%) |
| High +ve samples (10-99.9 mIU/mL) | 130 (65) | 82 (20.5) | 45 (45) | 257(36.7) |
| Low +ve samples (<10 mIU/mL) | 56 (28) | 238 (59.5) | 34 (34) | 328(46.9) |
| Negative samples (Non-responders) | 14 (7 ) | 80 (20 ) | 21 (21 ) | 115 (16.4) |
| Total positive samples | 186 (93) | 320 (80) | 79 (79) | 585 (83.6) |
- Citation: Abushady EA, Gameel MM, Klena JD, Ahmed SF, Abdel-Wahab KS, Fahmy SM. HBV vaccine efficacy and detection and genotyping of vaccineé asymptomatic breakthrough HBV infection in Egypt. World J Hepatol 2011; 3(6): 147-156
- URL: https://www.wjgnet.com/1948-5182/full/v3/i6/147.htm
- DOI: https://dx.doi.org/10.4254/wjh.v3.i6.147